Emergent BioSolutions Receives U.S. FDA Approval of Supplemental New Drug Application (sNDA) for NARCAN Nasal Spray Multipacks
- Approval will broaden the NARCAN
®Nasal Spray portfolio, and improve cost-effectiveness by increasing flexibility and distribution efficiency of this life-saving medication
GAITHERSBURG, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions (NYSE: EBS) announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for new multipack configurations of over-the-counter (OTC) NARCAN
“At Emergent, we work closely with our partners to develop solutions that help improve delivery, distribution and accessibility of NARCAN
This approval builds on Emergent's ongoing commitment to enhancing NARCAN
About NARCAN
NARCAN
About Emergent BioSolutions
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The "AI slowdown theory" can't stop the funding frenzy of model giants! Astra is launched, sparking heated discussions on AGI; OpenAI aims for a $1.2 trillion valuation
OpenAI is in early talks with investors to discuss a new round of financing, which would bring the valuation of ChatGPT's creator OpenAI to over $1.2 trillion. The company will subsequently conduct its initial public offering (IPO).

White House Pressure Fails to Prevent Hawkish Shift! Federal Reserve Rate Hike Looms, Waller-Trump Relationship Faces Major Test
The Federal Reserve is expected to raise interest rates by 25 basis points on Wednesday, marking the first increase since 2023; the market is pricing in a probability of over 90%, and the relationship between the White House and Walsh faces a test.

Firm Belief in Fed Rate Hike Tonight! US Bond Market Shows "Extreme Short Positions"
Japanese Yen flatlines ahead of Fed rate decicion
